Kyle B. Matchett

Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells

Yusuf A. Haggag, Kyle B. Matchett, El-Habib Dakir et al. · International Journal of Pharmaceutics · 2017 · 62 citations · Full text

Novel Anti-ran-gtpase Peptide, Peptide Engineering, Peptide Therapeutic +8

Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo

Yusuf A. Haggag, Kyle B. Matchett, Robert A. Falconer et al. · Cancers · 2019 · 43 citations · Full text

Advances in Precision Medicine: Tailoring Individualized Therapies

Kyle B. Matchett, Niamh Lynam‐Lennon, R. William G. Watson et al. · Cancers · 2017 · 39 citations · Full text

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

Ka Kui Chan, Kyle B. Matchett, Jonathan A. Coulter et al. · Oncotarget · 2017 · 38 citations · Full text

Cancer Research, Receptor Epor, Breast Oncology +15

Tibetan <i>PHD2</i> , an allele with loss-of-function properties

Daisheng Song, Bradleigh E. Navalsky, Wei Guan et al. · Proceedings of the National Academy of Sciences · 2020 · 38 citations · Full text